Trupanion Inc (NYSE:TRUP)‘s stock had its “buy” rating restated by stock analysts at Canaccord Genuity in a research report issued to clients and investors on Tuesday. They currently have a $35.00 price objective on the financial services provider’s stock, up from their prior price objective of $29.00. Canaccord Genuity’s target price would suggest a potential upside of 24.29% from the company’s previous close.
Several other equities analysts have also weighed in on TRUP. Zacks Investment Research lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Tuesday, October 17th. BidaskClub upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a research report on Friday, October 13th. Cowen and Company restated an “outperform” rating and set a $28.00 price target (up previously from $19.00) on shares of Trupanion in a research report on Wednesday, August 2nd. Stifel Nicolaus restated a “buy” rating and set a $24.00 price target (up previously from $18.00) on shares of Trupanion in a research report on Wednesday, August 2nd. Finally, Royal Bank Of Canada increased their price target on shares of Trupanion from $19.00 to $26.00 and gave the company an “outperform” rating in a research report on Wednesday, August 2nd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $27.50.
Trupanion (NYSE:TRUP) last announced its earnings results on Tuesday, August 1st. The financial services provider reported ($0.02) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.01. The company had revenue of $58.30 million during the quarter, compared to the consensus estimate of $57.58 million. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The firm’s revenue for the quarter was up 27.3% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.03) earnings per share.
In other Trupanion news, insider Darryl Rawlings sold 3,500 shares of the stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $21.13, for a total transaction of $73,955.00. Following the completion of the transaction, the insider now owns 1,449,505 shares in the company, valued at $30,628,040.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Margaret Tooth sold 4,500 shares of the stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $23.00, for a total transaction of $103,500.00. Following the transaction, the insider now owns 4,502 shares of the company’s stock, valued at approximately $103,546. The disclosure for this sale can be found here. Insiders have sold 147,052 shares of company stock valued at $3,662,969 in the last quarter.
A number of large investors have recently modified their holdings of TRUP. Handelsinvest Investeringsforvaltning boosted its position in shares of Trupanion by 598.3% in the second quarter. Handelsinvest Investeringsforvaltning now owns 209,500 shares of the financial services provider’s stock valued at $4,689,000 after acquiring an additional 179,500 shares during the period. American Century Companies Inc. bought a new position in shares of Trupanion in the second quarter valued at approximately $3,434,000. San Francisco Sentry Investment Group CA bought a new position in shares of Trupanion in the second quarter valued at approximately $2,972,000. Lagoda Investment Management L.P. bought a new position in shares of Trupanion in the second quarter valued at approximately $2,944,000. Finally, State Street Corp boosted its position in shares of Trupanion by 54.4% in the second quarter. State Street Corp now owns 346,367 shares of the financial services provider’s stock valued at $7,752,000 after acquiring an additional 121,990 shares during the period.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.